Tag: Vaccines

SEOUL (Reuters) – South Korea will almost certainly miss its goal of vaccinating 80% of its population to reach coronavirus “herd immunity” by November, the head of a doctors’ association whose advice helped the country contain the pandemic’s first wave said on Wednesday. The vaccination programme is due to start next week, after a procurement

SERRANA, Brazil (Reuters) – The COVID-19 vaccine developed by China’s Sinovac Biotech is effective against the UK and South African variants, the vaccine’s Brazilian partner said on Wednesday, citing test results in Chinese trials. “We have tested this vaccine in China against the English and the South African variants, with good results,” said Dimas Covas,

KUALA LUMPUR (Reuters) – Malaysia will extend its free COVID-19 vaccination programme to all foreigners residing in the country, including students, refugees and undocumented migrants, the government said on Thursday.FILE PHOTO: Foreign workers wait in line to be tested for the coronavirus disease (COVID-19) outside a clinic in Kajang, Malaysia October 26, 2020. REUTERS/Lim Huey

Despite the numerous advantages associated with worldwide vaccination, there remains a significant disparity in the availability of vaccines throughout the world. Image Credit: KiattisakCh/Shutterstock.com This limited availability is often due to the complex processes and high cost associated with producing a sustainable amount of vaccines. Recent research on the advancing technology of affinity chromatography shows

As 2020 comes to an end, only around 2.7 million Americans have received their first dose of the coronavirus vaccine — a much lower number than the 20 million the federal government originally promised. Nationwide distribution began on Dec. 14 after the Food and Drug Administration approved two vaccine candidates, one from Pfizer and another

A new episode of our podcast, “Show Me the Science,” has been posted. At present, these podcast episodes are highlighting research and patient care on the Washington University Medical Campus as our scientists and clinicians confront the COVID-19 pandemic. COVID-19 vaccine development has been rapid and successful. Two vaccines that report more than 90% efficacy

The United States has purchased an additional 100 million doses of the COVID-19 vaccine from Pfizer, enough to vaccinate around 50 million people, the U.S. Department of Health and Human Services announced Wednesday. The nearly $2 billion deal is the second one between the U.S. government and the pharmaceutical giant, bringing Pfizer's total commitment to

As cases of the novel coronavirus continue to surge across the country, progress on a second vaccine was made Thursday when the Food and Drug Administration (FDA) overwhelmingly endorsed Moderna's COVID-19 vaccine. A panel of FDA advisers recommended, in a 20-0 vote with one abstention, that the FDA move forward and authorize the Moderna vaccine

A new online calculator for estimating individual and community-level risk of dying from COVID-19 has been developed by researchers at the Johns Hopkins Bloomberg School of Public Health. The researchers who developed the calculator expect it to be useful to public health authorities for assessing mortality risks in different communities, and for prioritizing certain groups

Bahar Aliakbarian is an expert in supply chain management in pharmaceuticals and a professor at the School of Packaging at Michigan State University. Below, she describes the vaccine supply chains of Pfizer and Moderna, which are expected to be the two major early suppliers of the COVID-19 vaccines in the U.S. She also talks about

The United Kingdom has become the first country in the world to approve a COVID-19 vaccine, with doses of the Pfizer vaccine planned to be distributed as soon as next week. On Wednesday, the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) granted a temporary authorization for emergency use to the coronavirus vaccine developed by

The United States hopes to begin coronavirus vaccinations in early December, a top government health official said Sunday, the latest positive news to emerge even as cases surge across the worst-hit nation and elsewhere around the globe. The beginning of vaccinations could be a crucial shift in the battle against a virus that has claimed

Pfizer Inc. is updating the public about a promising step in reaching a safe COVID-19 vaccine. Earlier this month, the pharmaceutical company and its collaborator, BioNTech, announced that preliminary results from trials showed its potential vaccine was at least 90 percent effective. On Wednesday, Pfizer said after its phase three study, the vaccine has proven

The World Health Organization is discussing how best to allocate and prioritize COVID-19 vaccines when they arrive. It is focusing on the immediate crisis. To reduce deaths quickly when there are extremely limited vaccine doses available, vaccinating older, more vulnerable people is expected to be the best option, even if the vaccine is relatively poor

Similar to bacteria evolving resistance to antibiotics, viruses can evolve resistance to vaccines, and the evolution of SARS-CoV-2 could undermine the effectiveness of vaccines that are currently under development, according to a paper published November 9 in the open-access journal PLOS Biology by David Kennedy and Andrew Read from Pennsylvania State University, U.S. The authors

New York Gov. Andrew Cuomo. Photo: Michael M. Santiago/Getty Images New York Gov. Andrew Cuomo (D) said Thursday that the state will move forward with its own review process of coronavirus vaccines even if the Food and Drug Administration approves one or more for distribution and public use. Why it matters: The motion could sow

A revolutionary new way to give vaccines through microneedle skin patches is being tested at Swansea University, thanks to £200,000 of EU funding announced by the Welsh Government. The COVID-19 pandemic is giving extra urgency to the search for vaccines and new ways of delivering them. This important research is being conducted by Innoture, a

Activity from phony Twitter accounts established by the Russian Internet Research Agency (IRA) between 2015 and 2017 may have contributed to politicizing Americans’ position on the nature and efficacy of vaccines, a health care topic which has not historically fallen along party lines, according to new research published in the American Journal of Public Health.

President Donald Trump signed an executive order aimed at developing better flu vaccines to defend Americans against both seasonal influenza and the possibility of a future pandemic outbreak. Interested in Flu Season? Seasonal flu “kills tens of thousands of Americans each year,” Alex Azar, secretary of Health and Human Services, said in a statement. A

A new vaccine developed by Griffith University Institute for Glycomics researchers has the potential to treat and prevent toxic shock caused by invasive streptococcal disease, which kills more than 160,000 people every year. “Streptococcal toxic shock syndrome is an acute condition like meningococcus — if you get exposed to the organism you can be dead